Buffington Mohr Mc Neal Pfizer Inc Transaction History

Buffington Mohr Mc Neal

$605 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$26.13 - $33.94 $135,876 - $176,488	5,200 Added 41.77%	17,650 $508,000
Q3 2023 Oct 25, 2023	BUY	$32.09 - $37.51 $35,748 - $41,786	1,114 Added 9.83%	12,450 $412,000
Q2 2023 Jul 25, 2023	SELL	$36.12 - $41.79 $121,001 - $139,996	-3,350 Reduced 22.81%	11,336 $415,000
Q1 2023 Apr 26, 2023	SELL	$39.39 - $51.28 $27,297 - $35,537	-693 Reduced 4.51%	14,686 $599,000
Q4 2022 Jan 19, 2023	SELL	$41.75 - $54.5 $62,583 - $81,695	-1,499 Reduced 8.88%	15,379 $0
Q3 2022 Oct 11, 2022	BUY	$43.76 - $53.42 $4,069 - $4,968	93 Added 0.55%	16,878 $739,000
Q2 2022 Jul 19, 2022	BUY	$46.53 - $55.17 $71,981 - $85,347	1,547 Added 10.15%	16,785 $880,000
Q1 2022 May 02, 2022	BUY	$45.75 - $56.69 $45 - $56	1 Added 0.01%	15,238 $789,000
Q4 2021 Jan 27, 2022	BUY	$41.32 - $61.25 $127,554 - $189,078	3,087 Added 25.41%	15,237 $900,000
Q3 2021 Oct 13, 2021	BUY	$39.25 - $50.42 $39 - $50	1 Added 0.01%	12,150 $523,000
Q1 2021 Apr 14, 2021	BUY	$33.49 - $37.77 $94,408 - $106,473	2,819 Added 30.21%	12,149 $440,000
Q4 2020 Jan 20, 2021	BUY	$33.47 - $42.56 $2,978 - $3,787	89 Added 0.96%	9,330 $343,000
Q3 2020 Oct 26, 2020	SELL	$31.75 - $37.25 $31,750 - $37,250	-1,000 Reduced 9.76%	9,241 $339,000
Q2 2020 Jul 27, 2020	BUY	$30.12 - $36.54 $4,758 - $5,773	158 Added 1.57%	10,241 $335,000
Q4 2019 Jan 30, 2020	SELL	$32.92 - $37.36 $8,032 - $9,115	-244 Reduced 2.36%	10,083 $395,000
Q3 2019 Oct 10, 2019	BUY	$32.49 - $42.13 $13,515 - $17,526	416 Added 4.2%	10,327 $371,000
Q2 2019 Jul 31, 2019	SELL	$36.98 - $41.52 $1,220 - $1,370	-33 Reduced 0.33%	9,911 $429,000
Q1 2019 Apr 29, 2019	BUY	$37.5 - $41.2 $13,087 - $14,378	349 Added 3.64%	9,944 $422,000
Q3 2018 Oct 25, 2018	BUY	$34.47 - $41.81 $965 - $1,170	28 Added 0.29%	9,595 $423,000
Q2 2018 Jul 30, 2018	BUY	$32.98 - $35.16 $1,385 - $1,476	42 Added 0.44%	9,567 $347,000
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $295,275 - $325,278	9,525	9,525 $339,000

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$13.7 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.67 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.44 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.13 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buffington Mohr Mc Neal, based on Form 13F filings with the SEC.

News

Stay updated on Buffington Mohr Mc Neal with notifications on news.

Account